Help Comes in the Form of Biosensors for Cystic Fibrosis Patients
A new biosensor tool’s been developed by Imperial researchers that lights up when any harmful bacteria is detected in the lung. ...
Vertex Doubles Scholarship Program to Support the Academic and Professional Advancement of People Li
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) has doubled the number of scholarships for people living with cystic fibrosis (CF) and...
Mucociliary Clearence
Scott Donaldson, M.D., an associate professor of medicine and the director of the University of North Carolina adult CF center, provides...
#NACFC2017 – Latest Trial Data on Vertex CF Therapies and New Combos Show Benefits
Vertex Pharmaceuticals recently presented data from several clinical trials of cystic fibrosis treatments showing positive outcomes for...
MECFC 2018 Call for CF Research Abstracts is now open.
Abstracts containing exciting CF research that offer greater insight into pathophysiology, treatment or care of CF are eligible for...
MECFA opens registration to the 2nd Middle East CF Conference 2018.
Registration to the 2nd Middle East CF Conference is now open, please visit mecfa.org/registration to sign up today. The MECFC will take...
Current Screening Methods Miss CFTR Mutations in Certain Ethnic Groups
Rare mutations in the CFTR gene — which is defective in patients with cystic fibrosis (CF) — may occur in specific ethnic groups,...
The 1st Middle East CF Conference Muscat, Oman
The First Middle East Cystic Fibrosis Conference, organized by the Middle East Cystic Fibrosis Association, in collaboration with the...
International Experts Update Guidelines for Cystic Fibrosis Diagnosis
An international group of experts has updated the guidelines for the definite diagnosis of cystic fibrosis (CF), which will help...
